Clinical trial
Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
NCT06832878 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 1, 2026
- Completion date
- June 30, 2027
- Enrollment
- 101 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthroplasty